What did GenusPlus Group (ASX:GNP) announce regarding its capital raising?

GenusPlus Group announced it has secured firm commitments from institutional and sophisticated investors to raise A$200 million. The single-tranche placement involves issuing approximately 21.6 million new fully paid ordinary shares.

Why is GenusPlus Group (ASX:GNP) raising A$200 million?

The company is raising these funds to partly finance its strategic acquisition of MPC Kinetic Holdings Pty Ltd (MPK). GenusPlus entered into a binding agreement to acquire the business on 18 May 2026. Management has explicitly flagged the transaction as both transformational and highly accretive to earnings.

How does the placement price compare to the market price of GenusPlus Group (ASX:GNP)?

The new shares are priced at a fixed A$9.25 each, which represents a 5.0% discount to the last closing price of A$9.74 on 15 May 2026. This issue price also reflects a minor 1.5% discount to the five-day volume-weighted average price (VWAP) of A$9.39 up to that same date.

What does this capital raising mean for existing GenusPlus Group (ASX:GNP) retail shareholders?

Because this is an institutional placement rather than a pro-rata rights issue, regular retail shareholders face immediate ownership dilution as 21.6 million new shares enter the market.

How did the ASX market react to the GenusPlus Group (ASX:GNP) placement news?

Following a brief trading halt to finalise the bookbuild, GenusPlus shares resumed trading on Wednesday, 20 May 2026. The market reacted strongly and positively, driving the share price up to A$10.24 at the time of reporting. This is significantly higher than both the placement price of A$9.25 and the pre-halt closing price of A$9.74.

What are the key bull points for GenusPlus Group (ASX:GNP) after this announcement?

The primary bullish signal is the strong institutional backing for the placement, alongside management’s guidance that the MPC Kinetic acquisition is highly accretive. The immediate post-halt share price surge to A$10.24 also demonstrates robust market confidence in the strategic merits of the expansion.

Image for illustrative purposes only. Not a real photo.

GenusPlus raises $200M placement for MPK acquisition

Written by Mahathir BayenaPublished May 20, 2026, 1:30 AMLast Updated Jul 6, 2026, 10:11 AM

National essential power and communications infrastructure provider GenusPlus Group (ASX:GNP) secured commitments to raise $200 million through a single-tranche institutional placement.

The capital raise will issue approximately 21.6 million new fully paid ordinary shares at a fixed price of $9.25 per share, backed by existing institutional and sophisticated investors.

The placement price reflects a 5% discount to Genus’ last closing price of $9.74 on May 15 and a 1.5% discount to the five-day volume-weighted average price of $9.39 leading up to that date.

The company intends to deploy the proceeds to partly fund its strategic and highly accretive acquisition of MPC Kinetic, following a binding agreement announced on May 18.

Bell Potter Securities and Euroz Hartleys served as joint lead managers, while MA Moelis Australia acted as co-manager.

Following a brief trading halt, Genus resumed normal trading on the ASX on May 20, alongside the announcement of the placement results.

According to the company’s indicative timetable, settlement of the placement is slated for May 22.

The allotment and official trading commencement of the newly issued shares are expected on May 25. Genus anticipates completing the acquisition of MPK by July 1.

At the time of reporting, GenusPlus Group’s share price was $10.24.

GenusPlus raises $200M placement for MPK acquisition

Perguntas frequentes

Ativos relacionados a notícia